Clinical Trial Update: A Study of Melphalan Flufenamide (Melflufen)-Dex or Pomalidomide-dex for RRMM Patients Refractory to Lenalidomide [Phase 3]

View source ↗

Summary

Phase 3 trial of melphalan flufenamide (melflufen) with dexamethasone or pomalidomide-dexamethasone for relapsed/refractory multiple myeloma; the study was term…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• melphalan flufenamide (melphalan flufenamide)
• pomalidomide-dexamethasone (pomalidomide-dexamethasone)

Snippet

Sponsor: Oncopeptides AB | Conditions: Multiple Myeloma | Phase 3 | Status: TERMINATED | Results posted: 2022-07-27